Immunohistochemistry Applied to the Differential Diagnosis Between Ductal and Lobular Carcinoma of the Breast

被引:0
|
作者
Moura, Rafael de Deus [1 ]
Wludarski, Sheila C. L. [1 ]
Carvalho, Filomena M. [2 ]
Bacchi, Carlos E. [1 ]
机构
[1] Consultoria Patol, BR-18602010 Botucatu, SP, Brazil
[2] Univ Sao Paulo, Dept Pathol, Fac Med, BR-05508 Sao Paulo, Brazil
关键词
breast; ductal carcinoma; lobular carcinoma; E-cadherin; p120; E-CADHERIN EXPRESSION; IN-SITU; CLINICOPATHOLOGICAL ANALYSIS; NEOADJUVANT CHEMOTHERAPY; TUBULOLOBULAR CARCINOMA; CLINICAL-SIGNIFICANCE; MICROARRAY ANALYSIS; PROTEIN EXPRESSION; HISTOLOGICAL TYPE; GENE-EXPRESSION;
D O I
暂无
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
The distinction between classic lobular and ductal carcinoma, both in situ and invasive, has important therapeutic and management implications. Most ductal and lobular carcinomas are distinguished readily on hematoxylin-eosin-stained sections because of distinct histomorphologic features. In cases with ambiguous morphologic features, however, categorization in one or another type can be a challenge. Several immunohistochemical markers, including epithelial cadherin, p120, beta-catenin, and low-molecular-weight and high-molecular-weight cytokeratins among others, have been introduced to help better discriminate between lobular neoplasia and ductal carcinoma. In this critical review of the literature, we comment about the usefulness and the limitations of these markers to improve the accuracy in the differential diagnosis of breast pathology.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条